PTC
PTC Inc
$148.14▲ 1.57%as of 5/22/2026, 7:16:18 PM
1Y Price
Capitalization
- Market cap
- $17.1B
- Enterprise value
- $18B
- Total debt
- $1.4B
- Cash & equiv
- $439.1M
Valuation (CY26)
- EV / Rev
- 6.5x
- EV / EBITDA
- 20.1x
- EV / uFCF
- 20.3x
- P / E
- 18.2x
Yield & Margin (LTM)
- uFCF yield
- 7.5%
- EBITDA margin
- 43.1%
- NI margin
- 41.6%
- uFCF margin
- 42.7%
P&L
| Metric | LTM | CY26 | CY27 |
|---|---|---|---|
| Revenue ($B) | 3.0 | 2.8 | 2.9 |
| Growth Y/Y (%) | — | (5.7) | 6.3 |
| EBITDA ($B) | 1.3 | 0.9 | 1.0 |
| Margin (%) | 43.1 | 32.5 | 32.5 |
| Growth Y/Y (%) | — | (24.5) | 6.3 |
| uFCF ($B) | 1.3 | 0.9 | 0.9 |
| Margin (%) | 42.7 | 32.2 | 32.2 |
| Growth Y/Y (%) | — | (24.6) | 6.3 |
| Net Income ($B) | 1.2 | 1.0 | 1.1 |
| Margin (%) | 41.6 | 35.5 | 36.2 |
| Growth Y/Y (%) | — | (16.5) | 8.4 |
News
1dPTC's Codebeamer Powers Mazda's Software-Defined Vehicle DevelopmentPRNewsWire3dPTC Inc. (PTC) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference TranscriptSeeking Alpha9dPTC for Startups Program Helps Companies Design, Produce, and Launch Next-Generation ProductsPRNewsWire10dPTC Onshape Introduces Direct Altium Integration to Streamline ECAD-MCAD CollaborationPRNewsWire13dPTC Therapeutics: Sephience Turns The Story From Regulatory Repair To Operating LeverageSeeking Alpha14dPTC Therapeutics Q1 Earnings Call HighlightsMarketBeat15dPTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial ResultsPRNewsWire15dPTC Q2 Earnings & Revenues Beat on AI-Led ARR Strength, Shares JumpZacks Investment Research16dPTC Stock Surges Over 7% Overnight: Why Is It Moving?Benzinga16dPTC Inc. (PTC) Q2 2026 Earnings Call TranscriptSeeking Alpha16dHere's What Key Metrics Tell Us About PTC Inc. (PTC) Q2 EarningsZacks Investment Research16dPTC Inc. (PTC) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research